Australian by birth and Art Director by training, Rob has spent 27 years in communication, combining expertise in healthcare creative with strategic and leadership.
Rogers-led creative teams have been responsible for the launch and ongoing campaigns for many of the largest brands in healthcare history including billion dollar brands; Nexium, Celebrex, Actonel, Advair, Imitrex, Augmentin, Xigris, Botox and Lexapro. He has personally been awarded for creative efforts at major awards shows in New York, London and Sydney.
In 2006 Rob Rogers returned to the US to take up the position of Chief Creative Officer S&H, North America, in 2008 Rob was promoted to Co-CEO, the Americas, the position he currently holds.
Being creative in healthcare is tough. Information of scientific and medical complexity, a burdensome and increasingly restrictive regulatory environment, to say nothing of the ridiculous deadlines. I’m excited to be part of an initiative that offers healthcare creative folk the potential to gain the recognition they so clearly deserve, their very own CLIO!